Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131661) titled 'Hidabicin hydrochloride, subcutaneous injection of cytarabine and G-CSF Treatment of Myelodysplastic Syndrome IB2 with Lisatokela and adult secondary acute myeloid leukemia or elderly acute myeloid leukemia A prospective, multicenter, exploratory study of leukemia' on Sept. 4.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Condition:
AML&MDS
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-09-05
Target Sample Size: Experimental group:48;
Countries of Recruitment:
China
To know mo...